View the Whatcom County Respiratory Virus Dashboard Here
COVID-19 Updates for Providers Requested actions Be aware, U.S. Food and Drug Administration (FDA) granted full authorization to Moderna COVID-19 vaccine for people 18 years or older. Evidence shows the vaccine is safe and effective and manufactured with high quality. The vaccine will now be called Spikevax but has the same formulation as emergency use … 02/01/22 Health Advisory: FDA Provides Full Approval For Spikevax
COVID-19 Updates for Providers Requested actions Updated Antiviral Guidance Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit … 01/08/22 Health Advisory: CDC updated Antiviral Guidance; Booster Eligibility Expanded
COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) decision to strongly recommend a single Pfizer COVID-19 vaccine booster dose for people 12–17 years old at least 5 months after their primary series. This expands the age of booster access and strengthens … 01/06/22 Health Advisory: Booster Eligibility Expanded
COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and … 01/04/22 Health Advisory: CDC updated antiviral guidance
Requested Actions Be aware, Washington State is currently experiencing a shortage of anti-SARS-CoV-2 monoclonal antibodies (MAbs). Adhere to National Institutes of Health (NIH) guidelines on the use and prioritization of MAbs. Do not administer or prescribe Ivermectin for prevention or treatment of COVID-19. CDC issued a health alert about the rapid increase in Ivermectin prescriptions and reports … 11/08/21 Health Advisory: COVID-19 Monoclonal Antibody and Testing Updates
Requested Actions Be aware of the confusion between the terminology and guidance for 3rd dose versus booster doses. 3rd dose: vaccine doses available now for people who are considered moderately or severely immunocompromised On August 12, the Food and Drug Administration (FDA) amended its emergency use authorizations (EUAs) for Pfizer and Moderna COVID-19 vaccines to allow an additional (third) dose … 11/08/21 Health Advisory: COVID-19 Vaccine 3rd and Booster Doses
Requested actions Be aware, on Nov. 2, Centers for Disease Control and Prevention (CDC) recommended the Pfizer-BioNTech vaccine for children 5–11 years old under the Food and Drug Administration’s (FDA’s) emergency use authorization (EUA). Be aware, the U.S. is experiencing a shortage of BinaxNOW COVID-19 rapid antigen tests. Background COVID-19 vaccine for children 5–11 years … 11/08/21 Health Advisory: COVID-19 Vaccine For Ages 5-11
To report a confirmed or suspect case of pertussis, complete the or call . Overview Pertussis is common and very contagious. It is caused by Bordetella pertussis. The bacteria infect cilia in the upper respiratory tract. Early symptoms are mild, like the common cold. Patients often experience violent coughing fits (paroxysms). These can be followed by … Pertussis Fact Sheet
Overview Transmission: Fecal-oral. Incubation Period: Average 28-30 days (range 15-50 days). Symptoms: Anorexia, vomiting, abdominal pain, fatigue, followed by jaundice. Severity of illness increases with age. Infectious Period: 14 days prior to onset of jaundice to seven days after onset of jaundice. Infants can excrete virus in the stool for longer periods of time. Epidemiology: … Hepatitis A Fact Sheet
Action Requested Know how to order appropriate Zika virus testing through commercial laboratories. Background Because testing for Zika virus is now widely available through commercial laboratories, testing for Zika virus at Washington State Public Health Laboratories is now limited to: Patients for whom cost is a barrier to testing. Infants with possible congenital exposure to … Health Advisory: Zika Testing
